Marianna Dakanali, PhD

 Marianna Dakanali
Clinical Assistant Professor of Radiology
Medical School
Email:
[email protected]
Phone:
Available to mentor
Marianna Dakanali, PhD
Marianna Dakanali
Clinical Assistant Professor
  • Qualifications
  • Research Overview
  • Recent Publications

  • Manage Your Profile

    • Qualifications
    • Postdoctoral Fellow
      The University of Texas Southwestern Medical Center, Radiology, Dallas, United States
      2012 - 2015
      Postdoctoral Fellowship
    • Postdoctoral Fellow
      University of California, San Diego, Chemistry, San Diego, United States
      2009 - 2012
      Postdoctoral Fellowship
    • Visiting Fellow
      Helsinki University of Technology, Chemistry, Espoo, Finland
      2005 - 2005
      Other
    • Ph.D.
      Agricultural University of Athens, Athens, Greece
      2005 - 2008
    • M.Sc.
      University of Crete, Heraklion, Greece
      2001 - 2004
    • B.S.
      University of Crete, Heraklion, Greece
      1996 - 2001

    Research Overview

    My main research interests are the translation of radiopharmaceuticals for PET imaging and therapy for clinical applications, as well as the cGMP manufacture of PET radiopharmaceuticals. My work focuses on the USP <823> and federal regulations under 21 CFR part 212 for the production of radioactive drugs.

    Recent Publications

     See All Publications
    • Journal Article
      Assessment of PET drug adverse events in the U.S. since the implementation of 21 CFR part 212
      Dakanali M, VanBrocklin HF, Zigler SS, Scott PJH. EJNMMI Radiopharmacy and Chemistry, 2026 Jul 24; DOI:10.1186/s41181-026-00482-8
    • Journal Article
      Characterization of suspicious prostate lesions at multiparametric MRI with dynamic 68 Ga-Gozetotide PET/CT.
      Parrott D, Yuan Q, Pinho D, Xi Y, Costa DN, De Leon AD, Dakanali M, Sun X, Oz OK, Bowen S, Rofsky NM, Mathews D, Pedrosa I. EJNMMI Rep, 2025 Oct 13; 9 (1): 35 DOI:10.1186/s41824-025-00268-2
      PMID: PMC12515795
    • Journal Article
      Characterization of suspicious prostate lesions at multiparametric MRI with dynamic 68 Ga-Gozetotide PET/CT.
      Parrott D, Yuan Q, Pinho D, Xi Y, Costa DN, De Leon AD, Dakanali M, Sun X, Oz OK, Bowen S, Rofsky NM, Mathews D, Pedrosa I. EJNMMI Rep, 2025 Oct 13; 9 (1): 35 DOI:10.1186/s41824-025-00268-2
      PMID: PMC12515795
    • Journal Article
      Assessment of PET Drug Adverse Events Since the Implementation of 21 Code of Federal Regulations part 212
      Dakanali M, Scott PJH, VanBrocklin HF, Zigler SS. Journal of Nuclear Medicine, 2025 Mar 7; 66 ((supplement 1) 251366):
    • Journal Article
      Assessment of PET Drug Adverse Events Since the Implementation of 21 Code of Federal Regulations part 212
      Dakanali M, Scott PJH, VanBrocklin HF, Zigler SS. Journal of Nuclear Medicine, 2025 Mar 7; 66 ((supplement 1) 251366):
    • Journal Article
      FDA reconsiders rules around radiation dosimetry for first-in-human studies of investigational PET radiopharmaceuticals.
      Dakanali M, Zigler SS, Schwarz SW, Nickels ML, Oyama R, VanBrocklin HF, Scott PJH. Journal of Nuclear Medicine, 2025 Mar 10; 66 (6): 986 - 988. DOI:10.2967/jnumed.125.269885
    • Journal Article
      FDA reconsiders rules around radiation dosimetry for first-in-human studies of investigational PET radiopharmaceuticals.
      Dakanali M, Zigler SS, Schwarz SW, Nickels ML, Oyama R, VanBrocklin HF, Scott PJH. Journal of Nuclear Medicine, 2025 Mar 10; 66 (6): 986 - 988. DOI:10.2967/jnumed.125.269885
    • Preprint
      A Comparison of Routine [68Ga]Ga-PSMA-11 Preparation using Locametz and Illuccix Kits
      Wang IE, Morrissette LJ, Wong KK, Brooks AF, Dakanali M, Scott PJH. 2024 Dec 4; Research Square, DOI:10.21203/rs.3.rs-5363858/v1